Role of the low-affinity nerve growth factor receptor and the high-affinity Trk nerve growth factor receptor in human prostate carcinogenesis

Daniel Djakiew, Robert Delsite, Rakhi Dalal, Beth Pflug

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Nerve growth factor (NGF) interacts with a low-affinity NGF receptor (LNGFR) and a high-affinity Trk receptor in the paracrine regulation of human prostate growth. Both the LNGFR and the Trk receptor localize to the epithelia of the normal prostate. During malignant progression of the prostate, expression of the LNGFR is progressively lost from the epithelia, whereas Trk expression is retained in the epithelia of the adenomatous foci. Human prostatic stromal cell secretory protein (hPS) containing NGF stimulates autophosphorylation of the Trk receptor in a time- and concentration-dependent manner. This effect appears to be broadly based, because three distinct human prostate tumor cell lines (TSU-pr1, DU-145, and PC-3) were shown to undergo Trk autophosphorylation in response to treatment with hPS. These observations are of potential significance, because the LNGFR is thought to participate in the inhibition of prostate growth via apoptotic mechanisms, whereas the Trk receptor is thought to participate in the stimulation of prostate growth via initiation of a phosphorylation cascade. Therefore, loss of the LNGFR may eliminate an inhibitor of prostate growth as well as reducing competition for the NGF ligand, thereby enhancing a growth stimulus to the prostate tissues mediated via the Trk receptor. In this manner, an alteration in the balance of growth regulation between the inhibitory effect of the LNGFR and the stimulatory effect of the Trk receptor may play a causal role in prostate carcinogenesis.

Original languageEnglish (US)
Pages (from-to)333-339
Number of pages7
JournalRadiation Oncology Investigations
Volume3
Issue number6
StatePublished - 1996
Externally publishedYes

Fingerprint

Nerve Growth Factor Receptor
nerves
affinity
Prostate
Carcinogenesis
Nerve Growth Factor
epithelium
Growth
Epithelium
Growth Inhibitors
Stromal Cells
Tumor Cell Line
phosphorylation
stimulation
Phosphorylation
cultured cells
progressions
stimuli
inhibitors
Ligands

Keywords

  • LNGFR
  • NGF
  • Paracrine
  • Prostate
  • Trk

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Radiological and Ultrasound Technology

Cite this

Role of the low-affinity nerve growth factor receptor and the high-affinity Trk nerve growth factor receptor in human prostate carcinogenesis. / Djakiew, Daniel; Delsite, Robert; Dalal, Rakhi; Pflug, Beth.

In: Radiation Oncology Investigations, Vol. 3, No. 6, 1996, p. 333-339.

Research output: Contribution to journalArticle

@article{de7fb772187e4553a52797b059d774a6,
title = "Role of the low-affinity nerve growth factor receptor and the high-affinity Trk nerve growth factor receptor in human prostate carcinogenesis",
abstract = "Nerve growth factor (NGF) interacts with a low-affinity NGF receptor (LNGFR) and a high-affinity Trk receptor in the paracrine regulation of human prostate growth. Both the LNGFR and the Trk receptor localize to the epithelia of the normal prostate. During malignant progression of the prostate, expression of the LNGFR is progressively lost from the epithelia, whereas Trk expression is retained in the epithelia of the adenomatous foci. Human prostatic stromal cell secretory protein (hPS) containing NGF stimulates autophosphorylation of the Trk receptor in a time- and concentration-dependent manner. This effect appears to be broadly based, because three distinct human prostate tumor cell lines (TSU-pr1, DU-145, and PC-3) were shown to undergo Trk autophosphorylation in response to treatment with hPS. These observations are of potential significance, because the LNGFR is thought to participate in the inhibition of prostate growth via apoptotic mechanisms, whereas the Trk receptor is thought to participate in the stimulation of prostate growth via initiation of a phosphorylation cascade. Therefore, loss of the LNGFR may eliminate an inhibitor of prostate growth as well as reducing competition for the NGF ligand, thereby enhancing a growth stimulus to the prostate tissues mediated via the Trk receptor. In this manner, an alteration in the balance of growth regulation between the inhibitory effect of the LNGFR and the stimulatory effect of the Trk receptor may play a causal role in prostate carcinogenesis.",
keywords = "LNGFR, NGF, Paracrine, Prostate, Trk",
author = "Daniel Djakiew and Robert Delsite and Rakhi Dalal and Beth Pflug",
year = "1996",
language = "English (US)",
volume = "3",
pages = "333--339",
journal = "Radiation Oncology Investigations",
issn = "1065-7541",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Role of the low-affinity nerve growth factor receptor and the high-affinity Trk nerve growth factor receptor in human prostate carcinogenesis

AU - Djakiew, Daniel

AU - Delsite, Robert

AU - Dalal, Rakhi

AU - Pflug, Beth

PY - 1996

Y1 - 1996

N2 - Nerve growth factor (NGF) interacts with a low-affinity NGF receptor (LNGFR) and a high-affinity Trk receptor in the paracrine regulation of human prostate growth. Both the LNGFR and the Trk receptor localize to the epithelia of the normal prostate. During malignant progression of the prostate, expression of the LNGFR is progressively lost from the epithelia, whereas Trk expression is retained in the epithelia of the adenomatous foci. Human prostatic stromal cell secretory protein (hPS) containing NGF stimulates autophosphorylation of the Trk receptor in a time- and concentration-dependent manner. This effect appears to be broadly based, because three distinct human prostate tumor cell lines (TSU-pr1, DU-145, and PC-3) were shown to undergo Trk autophosphorylation in response to treatment with hPS. These observations are of potential significance, because the LNGFR is thought to participate in the inhibition of prostate growth via apoptotic mechanisms, whereas the Trk receptor is thought to participate in the stimulation of prostate growth via initiation of a phosphorylation cascade. Therefore, loss of the LNGFR may eliminate an inhibitor of prostate growth as well as reducing competition for the NGF ligand, thereby enhancing a growth stimulus to the prostate tissues mediated via the Trk receptor. In this manner, an alteration in the balance of growth regulation between the inhibitory effect of the LNGFR and the stimulatory effect of the Trk receptor may play a causal role in prostate carcinogenesis.

AB - Nerve growth factor (NGF) interacts with a low-affinity NGF receptor (LNGFR) and a high-affinity Trk receptor in the paracrine regulation of human prostate growth. Both the LNGFR and the Trk receptor localize to the epithelia of the normal prostate. During malignant progression of the prostate, expression of the LNGFR is progressively lost from the epithelia, whereas Trk expression is retained in the epithelia of the adenomatous foci. Human prostatic stromal cell secretory protein (hPS) containing NGF stimulates autophosphorylation of the Trk receptor in a time- and concentration-dependent manner. This effect appears to be broadly based, because three distinct human prostate tumor cell lines (TSU-pr1, DU-145, and PC-3) were shown to undergo Trk autophosphorylation in response to treatment with hPS. These observations are of potential significance, because the LNGFR is thought to participate in the inhibition of prostate growth via apoptotic mechanisms, whereas the Trk receptor is thought to participate in the stimulation of prostate growth via initiation of a phosphorylation cascade. Therefore, loss of the LNGFR may eliminate an inhibitor of prostate growth as well as reducing competition for the NGF ligand, thereby enhancing a growth stimulus to the prostate tissues mediated via the Trk receptor. In this manner, an alteration in the balance of growth regulation between the inhibitory effect of the LNGFR and the stimulatory effect of the Trk receptor may play a causal role in prostate carcinogenesis.

KW - LNGFR

KW - NGF

KW - Paracrine

KW - Prostate

KW - Trk

UR - http://www.scopus.com/inward/record.url?scp=0001159242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0001159242&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 333

EP - 339

JO - Radiation Oncology Investigations

JF - Radiation Oncology Investigations

SN - 1065-7541

IS - 6

ER -